Canada markets closed

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4000+0.1100 (+3.34%)
At close: 04:00PM EDT
3.4000 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts4455
Avg. Estimate-0.75-0.51-2.3-1.06
Low Estimate-1.19-0.56-3.24-1.22
High Estimate-0.5-0.46-1.61-0.78
Year Ago EPS-0.74-0.8-3.83-2.3
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts771010
Avg. Estimate56.63M68.21M281.72M382.52M
Low Estimate53.47M64M272.88M341M
High Estimate59.6M72.83M288M406.96M
Year Ago Sales49.33M58.13M234.04M281.72M
Sales Growth (year/est)14.80%17.30%20.40%35.80%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.7-0.78-0.85-0.72
EPS Actual-0.74-0.8-1.63-0.62
Difference-0.04-0.02-0.780.1
Surprise %-5.70%-2.60%-91.80%13.90%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.75-0.51-2.3-1.06
7 Days Ago-0.75-0.51-2.3-1.06
30 Days Ago-0.75-0.51-2.3-1.06
60 Days Ago-0.62-0.48-1.91-0.95
90 Days Ago-0.59-0.44-1.79-0.69
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesRVNCIndustrySector(s)S&P 500
Current Qtr.-1.40%N/AN/AN/A
Next Qtr.36.30%N/AN/AN/A
Current Year39.90%N/AN/AN/A
Next Year53.90%N/AN/AN/A
Next 5 Years (per annum)11.60%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A